Debiopharm Group - Crunchbase Company Profile & Funding

Q: Where is Debiopharm Group's headquarters?

Debiopharm Group is located in Lausanne, Vaud, Switzerland.

Q: Who invested in Debiopharm Group?

Debiopharm Group is funded by CARB-X.

Q: When was the last funding round for Debiopharm Group?

Debiopharm Group closed its last funding round on obfuscated from a Grant round.

Q: How much funding has Debiopharm Group raised to date?

Debiopharm Group has raised obfuscated.

Overview

Debiopharm Group

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Debiopharm Group

CB Rank

11877

Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.

Founded

obfuscation

Private

Grant

Lausanne, Vaud, Switzerland

251-500

www.debiopharm.com/

Biotechnology

Medical

Medical Device

Oncology

Pharmaceutical

Funding Rounds

Grant

OBF

obfuscation

Grant

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Thierry Mauvernay: President & Delegate of the Board
Sophie Genecand: Director, Real Estate department, Debiopharm Investment S.A.

Details

Legal Name

Debiopharm International SA

Operating Status

Active

Number of Exits

obfuscation

Company Type

For Profit

Founders

Rolland-Yves Mauvernay

About the Company

Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.

Phone Number

+41213210111

Predictions & Insights

Growth Insight

See this Growth Insight

Debiopharm Group is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Products & Services

Drug Development

Development of novel therapies by in-licensing promising compounds, focusing on oncology and infectious diseases to demonstrate safety and efficacy for global patient access.

Drug Manufacturing

Manufacturing of pharmaceutical products to support drug development and supply needs.

Research & Development

Debiopharm Group is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - Debiopharm Group	1	obfuscated obfuscation	—	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
CARB-X	—	Grant - Debiopharm Group	Erin Duffy
CARB-X	—	Grant - Debiopharm Group	Erin Duffy
CARB-X	—	Grant - Debiopharm Group	Erin Duffy
CARB-X	—	Grant - Debiopharm Group	Erin Duffy
CARB-X	—	Grant - Debiopharm Group	Erin Duffy

Investments

Investment Breakdown

Diversity Investments

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation
obfuscated obfuscation	ViewsML	—	Seed Round - ViewsML	obfuscated obfuscation

Diversity Investments

Number of Diversity Investments

Announced Date	Organization Name	Diversity Spotlight	Funding Round	Money Raised
obfuscated obfuscation	Immunexpress	Women Founded	Debt Financing - Immunexpress	obfuscated obfuscation
obfuscated obfuscation	Immunexpress	Women Founded	Series B - Immunexpress	obfuscated obfuscation
obfuscated obfuscation	Immunexpress	Women Founded	Venture Round - Immunexpress	obfuscated obfuscation
obfuscated obfuscation	Immunexpress	Women Founded	Venture Round - Immunexpress	obfuscated obfuscation